<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345832</id>
  <title nil="true"/>
  <common-name>2-[[4-(4-bromophenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-n-(2-phenylphenyl)acetamide</common-name>
  <description>2-[[4-(4-bromophenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-n-(2-phenylphenyl)acetamide is a chemical compound with the formula C27H20BrN5OS. With an average molecular weight of 542.50 g/mol, 2-[[4-(4-bromophenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-n-(2-phenylphenyl)acetamide is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>1588994</pubchem-id>
  <chemical-formula>C27H20BrN5OS</chemical-formula>
  <weight>542.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:50:35Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:50:35Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C=C1)C2=CC=CC=C2NC(=O)CSC3=NN=C(N3C4=CC=C(C=C4)Br)C5=CN=CC=C5</moldb-smiles>
  <moldb-formula>C27H20BrN5OS</moldb-formula>
  <moldb-inchi>InChI=1S/C27H20BrN5OS/c28-21-12-14-22(15-13-21)33-26(20-9-6-16-29-17-20)31-32-27(33)35-18-25(34)30-24-11-5-4-10-23(24)19-7-2-1-3-8-19/h1-17H,18H2,(H,30,34)</moldb-inchi>
  <moldb-inchikey>MXDGHJOAZCDBOH-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">541.05719</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341725</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[4-(4-bromophenyl)-5-pyridin-3-yl-1,2,4-triazol-3-yl]sulfanyl]-n-(2-phenylphenyl)acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Biphenyls and derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296186</sync-id>
  <structure-inchikey>MXDGHJOAZCDBOH-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000200000800000000800000000000000000000000002004000004002000000000000000004008000002084000000000004000000000000000000000000000000000000000000000000000020000000000000000000c08010000000000000010000000000000000000000000400000100000000000080000000000000100000000000800000000000000084880000010100000080000000000000000000000000000000000000080000000000000000410000000000002c00000100000000000020001000000100004000100000008000002000000200000000000000008040000000002040000000000400000008010000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJwAAAIABBkBoAAAAAwMBBkBoAAAA
AwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAAD
BAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAME
BwBoAAAAAwIBBgAoAAAAAwQIACgAAAADAgYAYAAAAAICEAAgAAAAAgZAKAAA
AAMEB0AoAAAAAwMHQCgAAAADAwZAKAAAAAMEB0AoAAAAAwMGQCgAAAADBAZA
aAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBIwAg
AAAAAQZAKAAAAAMEBkBoAAAAAwMBB0AoAAAAAwMGQGgAAAADAwEGQGgAAAAD
AwEGQGgAAAADAwELAAFoDAECaAwCA2gMAwRoDAQFaAwDBiAGB2gMBwhoDAgJ
aAwJCmgMCgtoDAsMIAwNIA0OKAINDwAPEAAQEQAREmgMEhNoDBMUaAwUFWgM
FRYgFhdoDBcYaAwYGWgMGRpoDBobaAwZHAAUHSAdHmgMHh9oDB8gaAwgIWgM
ISJoDAUAaAwLBmgMFRFoDBsWaAwiHWgMQgUAAAAGAAUEAwIBBgcICQoLBgUS
ERUUEwYXGBkaGxYGHh8gISIdFwQAAAAAAAAAFg==
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:45Z</structure-indexed-at>
</compound>
